{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:06:32Z","timestamp":1792515992214,"version":"4.5.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Prostate magnetic resonance imaging (MRI) has become a crucial tool in diagnosing and managing prostate cancer, mainly by helping to avoid unnecessary biopsies and enhancing the detection of clinically significant disease. However, its clinical usefulness is often limited by wide variation in how images are acquired, interpreted, and reported worldwide. This inconsistency affects diagnostic accuracy and patient outcomes. In response, the Quality Improvement Subgroup of the European Society of Urogenital Radiology (ESUR) Prostate MRI Working Group has created a practical, three-step quality-improvement framework aimed at standardising and improving prostate MRI practices. This framework consists of: Step 1: \u2018Build it right\u2019, establishing a foundation of technical excellence through adherence to the Prostate Imaging Reporting and Data System (PI-RADS) technical standards, objective quality assessment using the Prostate Imaging Quality (PI-QUAL) score, and systematic artefact reduction. Step 2: \u2018See it right\u2019, emphasising interpretive excellence via structured training, institutional quality assurance metrics, and multidisciplinary collaboration. Step 3: \u2018Improve and innovate\u2019, promoting continual refinement through emerging technologies such as AI-driven assessment, deep learning reconstruction, and remote supervision. By incorporating this structured approach into daily practice, this framework aims to ensure that prostate MRI consistently fulfils its promise of accurate, reproducible, and patient-centred care. A coordinated effort towards international implementation, benchmarking, and outcome-based validation represents the next critical step to maximise global impact.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Question<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>Wide variation in prostate MRI acquisition, image quality, and reporting undermines diagnostic accuracy. A structured roadmap is needed to ensure consistent quality and reproducible practice.<\/jats:italic>\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Findings<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>The ESUR Prostate MRI Working Group outlines a three-step framework\u00a0\u2014\u00a0\u2018Build it right\u2019, \u2018See it right\u2019, \u2018Improve and innovate\u2019\u00a0\u2014\u00a0to standardise acquisition, interpretation, and quality assurance.<\/jats:italic>\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Clinical relevance<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>Applying this roadmap in clinical practice aims to enhance diagnostic confidence and promote consistent, high-quality prostate cancer care across diverse healthcare settings.<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00330-026-12395-w","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T18:11:29Z","timestamp":1773425489000},"page":"5728-5744","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prostate MRI quality improvement: a Roadmap from the ESUR Prostate MRI Working Group"],"prefix":"10.1007","volume":"36","author":[{"given":"Adriano B.","family":"Dias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle","family":"Barentsz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronaldo Hueb","family":"Baroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Fali\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Gaudiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossano","family":"Girometti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan T.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"J\u00e4derling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Junker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido Matthias","family":"Kukuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Sofia L.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"L\u00f8gager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Puech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei S.","family":"Purysko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Uhlig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ursprung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Villeirs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Richenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5218-6431","authenticated-orcid":false,"given":"Francesco","family":"Giganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the ESUR Prostate MRI Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"12395_CR1","unstructured":"EAU Guidelines. Edn. presented at the EAU Annual Congress Madrid (2025). Available via https:\/\/uroweb.org\/guidelines\/prostate-cancer. Accessed 18 Aug 2025"},{"key":"12395_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.eururo.2019.06.023","volume":"77","author":"F-JH Drost","year":"2020","unstructured":"Drost F-JH, Osses D, Nieboer D et al (2020) Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a Cochrane systematic review and meta-analysis. Eur Urol 77:78\u201394. https:\/\/doi.org\/10.1016\/j.eururo.2019.06.023","journal-title":"Eur Urol"},{"key":"12395_CR3","doi-asserted-by":"publisher","first-page":"E123","DOI":"10.1148\/rg.210134","volume":"42","author":"DN Santos","year":"2022","unstructured":"Santos DN, Horvat N, Dias AB et al (2022) Prostate cancer imaging: what we already know and what is on the horizon. Radiographics 42:E123\u2013E124. https:\/\/doi.org\/10.1148\/rg.210134","journal-title":"Radiographics"},{"key":"12395_CR4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.eururo.2024.08.022","volume":"87","author":"V Kasivisvanathan","year":"2025","unstructured":"Kasivisvanathan V, Chan VW-S, Clement KD et al (2025) VISION: an individual patient data meta-analysis of randomised trials comparing magnetic resonance imaging-targeted biopsy with standard transrectal ultrasound-guided biopsy in the detection of prostate cancer. Eur Urol 87:512\u2013523","journal-title":"Eur Urol"},{"key":"12395_CR5","doi-asserted-by":"crossref","first-page":"6168","DOI":"10.1007\/s00330-024-10626-6","volume":"34","author":"AR Padhani","year":"2024","unstructured":"Padhani AR, Godtman RA, Schoots IG (2024) Key learning on the promise and limitations of MRI in prostate cancer screening. Eur Radiol 34:6168\u20136174","journal-title":"Eur Radiol"},{"key":"12395_CR6","doi-asserted-by":"publisher","unstructured":"da Cruz Fagundes M, Almeida Coelho FM, Naves GG et al (2025) Advances in prostate cancer imaging: from detection to post-treatment. Abdom Radiol (NY) https:\/\/doi.org\/10.1007\/s00261-025-05042-3","DOI":"10.1007\/s00261-025-05042-3"},{"key":"12395_CR7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.euo.2023.01.003","volume":"6","author":"CM Moore","year":"2023","unstructured":"Moore CM, King LE, Withington J et al (2023) Best current practice and research priorities in active surveillance for prostate cancer\u2014a report of a Movember international consensus meeting. Eur Urol Oncol 6:160\u2013182","journal-title":"Eur Urol Oncol"},{"key":"12395_CR8","doi-asserted-by":"publisher","first-page":"7716","DOI":"10.1007\/s00330-024-10863-9","volume":"34","author":"AB Dias","year":"2024","unstructured":"Dias AB, Woo S, Leni R et al (2024) Is MRI ready to replace biopsy during active surveillance? Eur Radiol 34:7716\u20137727. https:\/\/doi.org\/10.1007\/s00330-024-10863-9","journal-title":"Eur Radiol"},{"key":"12395_CR9","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.euo.2021.01.003","volume":"4","author":"V Panebianco","year":"2021","unstructured":"Panebianco V, Villeirs G, Weinreb JC et al (2021) Prostate magnetic resonance imaging for local recurrence reporting (PI-RR): international consensus-based guidelines on multiparametric magnetic resonance imaging for prostate cancer recurrence after radiation therapy and radical prostatectomy. Eur Urol Oncol 4:868\u2013876. https:\/\/doi.org\/10.1016\/j.euo.2021.01.003","journal-title":"Eur Urol Oncol"},{"key":"12395_CR10","doi-asserted-by":"publisher","first-page":"852","DOI":"10.2214\/AJR.22.28665","volume":"220","author":"J Abreu-Gomez","year":"2023","unstructured":"Abreu-Gomez J, Dias AB, Ghai S (2023) PI-RR: the Prostate Imaging for Recurrence Reporting System for MRI assessment of local prostate cancer recurrence after radiation therapy or radical prostatectomy\u2014a review. AJR Am J Roentgenol 220:852\u2013861. https:\/\/doi.org\/10.2214\/AJR.22.28665","journal-title":"AJR Am J Roentgenol"},{"key":"12395_CR11","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1007\/s00330-023-09680-3","volume":"33","author":"P Puech","year":"2023","unstructured":"Puech P, Gutierrez PA, Berg-L\u00f8gager V et al (2023) How should we prepare a generation of radiologists for MRI-based prostate cancer screening? Eur Radiol 33:7212\u20137214","journal-title":"Eur Radiol"},{"key":"12395_CR12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41585-022-00648-4","volume":"20","author":"T Barrett","year":"2023","unstructured":"Barrett T, de Rooij M, Giganti F et al (2023) Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway. Nat Rev Urol 20:9\u201322","journal-title":"Nat Rev Urol"},{"key":"12395_CR13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.eururo.2019.03.023","volume":"75","author":"O Rouvi\u00e8re","year":"2019","unstructured":"Rouvi\u00e8re O, Schoots IG, Mottet N et al (2019) Multiparametric magnetic resonance imaging before prostate biopsy: a chain is only as strong as its weakest link. Eur Urol 75:889\u2013890","journal-title":"Eur Urol"},{"key":"12395_CR14","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1007\/s00261-024-04396-4","volume":"49","author":"FMA Coelho","year":"2024","unstructured":"Coelho FMA, Baroni RH (2024) Strategies for improving image quality in prostate MRI. Abdom Radiol (NY) 49:4556\u20134573","journal-title":"Abdom Radiol"},{"key":"12395_CR15","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1007\/s00330-020-06929-z","volume":"30","author":"M de Rooij","year":"2020","unstructured":"de Rooij M, Isra\u00ebl B, Tummers M et al (2020) ESUR\/ESUI consensus statements on multiparametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists\u2019 training. Eur Radiol 30:5404\u20135416","journal-title":"Eur Radiol"},{"key":"12395_CR16","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20211372","volume":"95","author":"E Karanasios","year":"2022","unstructured":"Karanasios E, Caglic I, Zawaideh JP et al (2022) Prostate MRI quality: clinical impact of the PI-QUAL score in prostate cancer diagnostic work-up. Br J Radiol 95:20211372","journal-title":"Br J Radiol"},{"key":"12395_CR17","doi-asserted-by":"publisher","unstructured":"Cheng Y, Shen L, Liao Q et al (2025) Multi-reader evaluation of the prostate imaging quality score system version 2 (PI-QUAL V2) and its clinical application. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-025-11667-1","DOI":"10.1007\/s00330-025-11667-1"},{"key":"12395_CR18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.110849","volume":"164","author":"G Brembilla","year":"2023","unstructured":"Brembilla G, Lavalle S, Parry T et al (2023) Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy. Eur J Radiol 164:110849","journal-title":"Eur J Radiol"},{"key":"12395_CR19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2022.110431","volume":"154","author":"N P\u00f6tsch","year":"2022","unstructured":"P\u00f6tsch N, Rainer E, Clauser P et al (2022) Impact of PI-QUAL on PI-RADS and cancer yield in an MRI-TRUS fusion biopsy population. Eur J Radiol 154:110431","journal-title":"Eur J Radiol"},{"key":"12395_CR20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.110733","volume":"161","author":"AM H\u00f6tker","year":"2023","unstructured":"H\u00f6tker AM, Njoh S, Hofer LJ et al (2023) Multi-reader evaluation of different image quality scoring systems in prostate MRI. Eur J Radiol 161:110733","journal-title":"Eur J Radiol"},{"key":"12395_CR21","volume":"189","author":"JI Shin","year":"2025","unstructured":"Shin JI, Park KJ, Park MY et al (2025) Diagnostic performance of biparametric MRI according to prostate imaging quality (PI-QUAL) version 2: analysis of multi-institutional data. Eur J Radiol 189:112209","journal-title":"Eur J Radiol"},{"key":"12395_CR22","volume":"166","author":"A Ponsiglione","year":"2023","unstructured":"Ponsiglione A, Stanzione A, Califano G et al (2023) MR image quality in local staging of prostate cancer: role of PI-QUAL in the detection of extraprostatic extension. Eur J Radiol 166:110973","journal-title":"Eur J Radiol"},{"key":"12395_CR23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.euros.2022.11.013","volume":"47","author":"O Windisch","year":"2023","unstructured":"Windisch O, Benamran D, Dariane C et al (2023) Role of the prostate imaging quality (PI-QUAL) score for prostate magnetic resonance image quality in pathological upstaging after radical prostatectomy: a multicentre European study. Eur Urol Open Sci 47:94\u2013101","journal-title":"Eur Urol Open Sci"},{"key":"12395_CR24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.euo.2020.06.007","volume":"3","author":"F Giganti","year":"2020","unstructured":"Giganti F, Allen C, Emberton M et al (2020) Prostate imaging quality (PI-QUAL): a new quality control scoring system for multiparametric magnetic resonance imaging of the prostate from the PRECISION trial. Eur Urol Oncol 3:615\u2013619. https:\/\/doi.org\/10.1016\/j.euo.2020.06.007","journal-title":"Eur Urol Oncol"},{"key":"12395_CR25","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.1007\/s00330-024-10795-4","volume":"34","author":"M de Rooij","year":"2024","unstructured":"de Rooij M, Allen C, Twilt JJ et al (2024) PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI. Eur Radiol 34:7068\u20137079","journal-title":"Eur Radiol"},{"key":"12395_CR26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2024.111716","volume":"181","author":"A Ponsiglione","year":"2024","unstructured":"Ponsiglione A, Cereser L, Spina E et al (2024) PI-QUAL version 2: a multi-reader reproducibility study on multiparametric MRI from a tertiary referral center. Eur J Radiol 181:111716","journal-title":"Eur J Radiol"},{"key":"12395_CR27","first-page":"3096","volume":"35","author":"KL Lee","year":"2025","unstructured":"Lee KL, Caglic I, Liao PH et al (2025) PI-QUAL version 2 image quality categorisation and inter-reader agreement compared to version 1. Eur Radiol 35:3096\u20133104","journal-title":"Eur Radiol"},{"key":"12395_CR28","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.231130","volume":"309","author":"F Giganti","year":"2023","unstructured":"Giganti F, Ng A, Asif A et al (2023) Global variation in magnetic resonance imaging quality of the prostate. Radiology 309:e231130","journal-title":"Radiology"},{"key":"12395_CR29","doi-asserted-by":"publisher","unstructured":"Ng ABCD, Asif A, Agarwal R et al (2025) Biparametric vs multiparametric MRI for prostate cancer diagnosis: the PRIME diagnostic clinical trial. JAMA. https:\/\/doi.org\/10.1001\/jama.2025.13722","DOI":"10.1001\/jama.2025.13722"},{"key":"12395_CR30","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1007\/s00261-024-04617-w","volume":"50","author":"J Palmer","year":"2025","unstructured":"Palmer J, Winata L, Seale M et al (2025) Micro-enema immediately prior to prostate MRI: effects on rectal gas, image quality and PI-QUAL score. Abdom Radiol (NY) 50:1662\u20131671. https:\/\/doi.org\/10.1007\/s00261-024-04617-w","journal-title":"Abdom Radiol"},{"key":"12395_CR31","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1007\/s00261-020-02487-6","volume":"45","author":"M Coskun","year":"2020","unstructured":"Coskun M, Mehralivand S, Shih JH et al (2020) Impact of bowel preparation with Fleet\u2019sTM enema on prostate MRI quality. Abdom Radiol (NY) 45:4252\u20134259. https:\/\/doi.org\/10.1007\/s00261-020-02487-6","journal-title":"Abdom Radiol"},{"key":"12395_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2023.110758","volume":"162","author":"S Prabhakar","year":"2023","unstructured":"Prabhakar S, Schieda N (2023) Patient preparation for prostate MRI: a scoping review. Eur J Radiol 162:110758. https:\/\/doi.org\/10.1016\/j.ejrad.2023.110758","journal-title":"Eur J Radiol"},{"key":"12395_CR33","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1007\/s00330-023-10345-4","volume":"34","author":"H Nakai","year":"2024","unstructured":"Nakai H, Takahashi H, Adamo DA et al (2024) Decreased prostate MRI cancer detection rate due to moderate to severe susceptibility artifacts from hip prosthesis. Eur Radiol 34:3387\u20133399. https:\/\/doi.org\/10.1007\/s00330-023-10345-4","journal-title":"Eur Radiol"},{"key":"12395_CR34","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1007\/s00261-024-04483-6","volume":"49","author":"H Nakai","year":"2024","unstructured":"Nakai H, Takahashi N, Sugi MD et al (2024) Image quality comparison of 1.5T and 3T prostate MRIs of the same post-hip arthroplasty patients: multi-rater assessments including PI-QUAL version 2. Abdom Radiol (NY) 49:3913\u20133924. https:\/\/doi.org\/10.1007\/s00261-024-04483-6","journal-title":"Abdom Radiol"},{"key":"12395_CR35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1148\/radiol.2020190646","volume":"296","author":"AC Westphalen","year":"2020","unstructured":"Westphalen AC, McCulloch CE, Anaokar JM et al (2020) Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers. Radiology 296:76\u201384","journal-title":"Radiology"},{"key":"12395_CR36","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1007\/s00330-019-06654-2","volume":"30","author":"G Brembilla","year":"2020","unstructured":"Brembilla G, Dell\u2019Oglio P, Stabile A et al (2020) Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1. Eur Radiol 30:3383\u20133392","journal-title":"Eur Radiol"},{"key":"12395_CR37","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1148\/radiol.2016152542","volume":"280","author":"AB Rosenkrantz","year":"2016","unstructured":"Rosenkrantz AB, Ginocchio LA, Cornfeld D et al (2016) Interobserver reproducibility of the PI-RADS version 2 lexicon: a multicenter study of six experienced prostate radiologists. Radiology 280:793\u2013804","journal-title":"Radiology"},{"key":"12395_CR38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bju.15285","volume":"127","author":"T Barrett","year":"2021","unstructured":"Barrett T, Padhani AR, Patel A et al (2021) Certification in reporting multiparametric magnetic resonance imaging of the prostate: recommendations of a UK consensus meeting. BJU Int 127:304\u2013306","journal-title":"BJU Int"},{"key":"12395_CR39","unstructured":"German Radiological Society (2018) Certification mpMRI of the prostate. Available via https:\/\/www.ag-uro.drg.de\/de-DE\/4285\/zertifizierung\/. Accessed 18 Aug 2025"},{"key":"12395_CR40","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1007\/s00261-020-02725-x","volume":"45","author":"N Tan","year":"2020","unstructured":"Tan N, Lakshmi M, Hernandez D, Scuderi A (2020) Upcoming American College of Radiology prostate MRI designation launching: what to expect. Abdom Radiol (NY) 45:4109\u20134111","journal-title":"Abdom Radiol"},{"key":"12395_CR41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bju.14361","volume":"122","author":"M Brizmohun Appayya","year":"2018","unstructured":"Brizmohun Appayya M, Adshead J, Ahmed HU et al (2018) National implementation of multi-parametric magnetic resonance imaging for prostate cancer detection: recommendations from a UK consensus meeting. BJU Int 122:13\u201325","journal-title":"BJU Int"},{"key":"12395_CR42","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.crad.2013.03.030","volume":"68","author":"APS Kirkham","year":"2013","unstructured":"Kirkham APS, Haslam P, Keanie JY et al (2013) Prostate MRI: who, when, and how? Report from a UK consensus meeting. Clin Radiol 68:1016\u20131023","journal-title":"Clin Radiol"},{"key":"12395_CR43","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.eururo.2013.03.030","volume":"64","author":"CM Moore","year":"2013","unstructured":"Moore CM, Kasivisvanathan V, Eggener S et al (2013) Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol 64:544\u2013552","journal-title":"Eur Urol"},{"key":"12395_CR44","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","volume":"75","author":"M van der Leest","year":"2019","unstructured":"van der Leest M, Cornel E, Israel B et al (2019) Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate MRI with subsequent MRI-guided biopsy in biopsy-na\u00efve men with elevated PSA: a large prospective multicentre clinical study. Eur Urol 75:570\u2013578","journal-title":"Eur Urol"},{"key":"12395_CR45","doi-asserted-by":"publisher","unstructured":"O\u2019Toole C, Boakye NF, Hannigan A et al (2025) Clinical impact of MRI-based risk calculators for prostate cancer diagnosis: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. https:\/\/doi.org\/10.1038\/s41391-025-01014-2","DOI":"10.1038\/s41391-025-01014-2"},{"key":"12395_CR46","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s00330-016-4635-5","volume":"27","author":"NL Hansen","year":"2017","unstructured":"Hansen NL, Koo BC, Gallagher FA, et al (2017) Comparison of initial and tertiary centre second opinion reads of multiparametric magnetic resonance imaging of the prostate prior to repeat biopsy. Eur Radiol. 27:2259\u20132266","journal-title":"Eur Radiol"},{"key":"12395_CR47","doi-asserted-by":"crossref","first-page":"781.e1","DOI":"10.1016\/j.urolonc.2021.01.008","volume":"39","author":"TH Ecke","year":"2021","unstructured":"Ecke TH, Schwaiger D, Nesterov G, et al (2021) Comparison of initial and second opinion reads of multiparametric magnetic resonance imaging of the prostate for transperineal template-guided biopsies with MRI-Ultrasound fusion. Urol Oncol. 39:781.e1\u2013781.e7","journal-title":"Urol Oncol."},{"key":"12395_CR48","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.eururo.2019.05.029","volume":"76","author":"M van der Leest","year":"2019","unstructured":"van der Leest M, Isra\u00ebl B, Cornel EB et al (2019) High diagnostic performance of short magnetic resonance imaging protocols for prostate cancer detection in biopsy-na\u00efve men: the next step in magnetic resonance imaging accessibility. Eur Urol 76:574\u2013581","journal-title":"Eur Urol"},{"key":"12395_CR49","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s00261-019-01934-3","volume":"44","author":"M Gatti","year":"2019","unstructured":"Gatti M, Faletti R, Calleris G et al (2019) Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI). Abdom Radiol (NY) 44:1883\u20131893","journal-title":"Abdom Radiol"},{"key":"12395_CR50","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s11523-022-00925-7","volume":"17","author":"ND Shore","year":"2022","unstructured":"Shore ND, Morgans AK, El-Haddad G et al (2022) Addressing challenges and controversies in the management of prostate cancer with multidisciplinary teams. Target Oncol 17:709\u2013725","journal-title":"Target Oncol"},{"key":"12395_CR51","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.euo.2022.06.007","volume":"5","author":"S Kotamarti","year":"2022","unstructured":"Kotamarti S, Gupta RT, Wang B et al (2022) Reconciling discordance between prostate biopsy histology and magnetic resonance imaging suspicion: implementation of a quality improvement protocol of imaging re-review and reverse-fusion target analysis. Eur Urol Oncol 5:483\u2013493","journal-title":"Eur Urol Oncol"},{"key":"12395_CR52","unstructured":"American College of Radiology (2025) Diagnostic Imaging Center of Excellence (DICOE) 2025. Available via https:\/\/www.acr.org\/Accreditation\/Designations\/Diagnostic-Imaging-Center-of-Excellence. Accessed 20 Aug 2025"},{"key":"12395_CR53","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.jacr.2024.04.008","volume":"21","author":"AS Purysko","year":"2024","unstructured":"Purysko AS, Zacharias-Andrews K, Tomkins KG, et al (2024) Improving Prostate MR Image Quality in Practice-Initial Results From the ACR Prostate MR Image Quality Improvement Collaborative. J Am Coll Radiol. 21:1464\u20131474","journal-title":"J Am Coll Radiol"},{"key":"12395_CR54","doi-asserted-by":"publisher","unstructured":"Knott E, Bullen J, Harris R et al (2025) Improving prostate MRI quality and its diagnostic impact: a prospective quality improvement initiative. Abdom Radiol (NY) https:\/\/doi.org\/10.1007\/s00261-025-05011-w","DOI":"10.1007\/s00261-025-05011-w"},{"key":"12395_CR55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.111091","volume":"168","author":"H Fleming","year":"2023","unstructured":"Fleming H, Dias AB, Talbot N et al (2023) Inter-reader variability and reproducibility of the PI-QUAL score in a multicentre setting. Eur J Radiol 168:111091","journal-title":"Eur J Radiol"},{"key":"12395_CR56","first-page":"108","volume":"15","author":"N Perlis","year":"2021","unstructured":"Perlis N, Finelli A, Berlin A et al (2021) Creating patient-centered radiology reports to empower patients undergoing prostate MRI. Can Urol Assoc J 15:108\u2013113","journal-title":"Can Urol Assoc J"},{"key":"12395_CR57","first-page":"6857","volume":"30","author":"N Perlis","year":"2022","unstructured":"Perlis N, Finelli A, Lovas M et al (2022) Exploring the value of using patient-oriented MRI reports in clinical practice\u2014a pilot study. Support Care Cancer 30:6857\u20136876","journal-title":"Support Care Cancer"},{"key":"12395_CR58","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/bco2.351","volume":"5","author":"R Sutherland","year":"2024","unstructured":"Sutherland R, Gross CP, Ma X et al (2024) \u201cIt just makes sense to me\u201d: a qualitative study exploring patient decision-making and experiences with prostate MRI during active surveillance. BJUI Compass 5:593\u2013601","journal-title":"BJUI Compass"},{"key":"12395_CR59","doi-asserted-by":"crossref","first-page":"e054045","DOI":"10.1136\/bmjopen-2021-054045","volume":"12","author":"SWD Merriel","year":"2022","unstructured":"Merriel SWD, Archer S, Forster AS et al (2022) Experiences of \u2018traditional\u2019 and \u2018one-stop\u2019 MRI-based prostate cancer diagnostic pathways in England: a qualitative study with patients and GPs. BMJ Open 12:e054045","journal-title":"BMJ Open"},{"key":"12395_CR60","unstructured":"D\u2019Costa ZU, Margolis DJ, McClure T et al (2022) The effect of radiologist\u2013patient interaction: are patients benefitting from patient centered communication before prostate image-guided interventions? A quality improvement report. Available via https:\/\/www.rsna.org\/-\/media\/files\/rsna\/practice-tools\/quality-improvement\/quality-improvement-reports\/2022\/the-effect-of-radiologist-patient-m5a-qi-6.pdf?rev=02b43b7755924002b1c5a1ad71d2415c&hash=E2E25F1888CF4F062B5B78C21851282D. Accessed 20 Aug 2025"},{"key":"12395_CR61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2024.111581","volume":"177","author":"J Kluckert","year":"2024","unstructured":"Kluckert J, H\u00f6tker AM, Da Mutten R et al (2024) AI-based automated evaluation of image quality and protocol tailoring in patients undergoing MRI for suspected prostate cancer. Eur J Radiol 177:111581","journal-title":"Eur J Radiol"},{"key":"12395_CR62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.110924","volume":"165","author":"D Alis","year":"2023","unstructured":"Alis D, Kartal MS, Seker ME et al (2023) Deep learning for assessing image quality in bi-parametric prostate MRI: a feasibility study. Eur J Radiol 165:110924","journal-title":"Eur J Radiol"},{"key":"12395_CR63","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s41747-025-00584-z","volume":"9","author":"JN Gloe","year":"2025","unstructured":"Gloe JN, Borisch EA, Froemming AT et al (2025) Deep learning for quality assessment of axial T2-weighted prostate MRI: a tool to reduce unnecessary rescanning. Eur Radiol Exp 9:44. https:\/\/doi.org\/10.1186\/s41747-025-00584-z","journal-title":"Eur Radiol Exp"},{"key":"12395_CR64","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.acra.2023.09.030","volume":"31","author":"MJ Belue","year":"2024","unstructured":"Belue MJ, Law YM, Marko J et al (2024) Deep learning-based interpretable AI for prostate T2W MRI quality evaluation. Acad Radiol 31:1429\u20131437","journal-title":"Acad Radiol"},{"key":"12395_CR65","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s41747-021-00245-x","volume":"5","author":"F Giganti","year":"2021","unstructured":"Giganti F, Lindner S, Piper JW et al (2021) Multiparametric prostate MRI quality assessment using a semi-automated PI-QUAL software program. Eur Radiol Exp 5:48","journal-title":"Eur Radiol Exp"},{"key":"12395_CR66","unstructured":"Quibim (2023) Quibim enhances flagship QP Prostate\u00ae product with the launch of AI-QUALTM: industry-first AI tool for automated prostate MRI image quality assessment based on PI-QUAL. Quibim, Valencia. Available via https:\/\/quibim.com\/news\/quibim-enhances-flagship-qp-prostate-product-with-the-launch-of-ai-qual\/. Accessed 10 Feb 2025"},{"key":"12395_CR67","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3390\/jpm15070284","volume":"15","author":"S Ursprung","year":"2025","unstructured":"Ursprung S, Agrotis G, van Houdt PJ et al (2025) Prostate MRI using deep learning reconstruction in response to cancer screening demands: a systematic review and meta-analysis. J Pers Med 15:284. https:\/\/doi.org\/10.3390\/jpm15070284","journal-title":"J Pers Med"},{"key":"12395_CR68","doi-asserted-by":"crossref","DOI":"10.1148\/rg.220133","volume":"43","author":"S Kiryu","year":"2023","unstructured":"Kiryu S, Akai H, Yasaka K et al (2023) Clinical impact of deep learning reconstruction in MRI. Radiographics 43:e220133","journal-title":"Radiographics"},{"key":"12395_CR69","unstructured":"American College of Radiology. Breast Imaging Reporting and Data System (BI-RADS\u00ae) Atlas (2025) American College of Radiology, Reston. Available via https:\/\/www.acr.org\/Clinical-Resources\/Reporting-and-DataSystems\/Bi-Rads. Accessed 20 Aug 2025"},{"key":"12395_CR70","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.24.30956","volume":"224","author":"AB Dias","year":"2025","unstructured":"Dias AB, Chang SD, Fennessy FM et al (2025) New prostate MRI scoring systems (PI-QUAL, PRECISE, PI-RR, and PI-FAB): AJR Expert Panel narrative review. AJR Am J Roentgenol 224:e2430956. https:\/\/doi.org\/10.2214\/AJR.24.30956","journal-title":"AJR Am J Roentgenol"},{"key":"12395_CR71","doi-asserted-by":"publisher","first-page":"7481","DOI":"10.1007\/s00330-024-10792-7","volume":"34","author":"A Ponsiglione","year":"2024","unstructured":"Ponsiglione A, Brembilla G, Cuocolo R et al (2024) ESR Essentials: using the right scoring system in prostate MRI\u2014practice recommendations by ESUR. Eur Radiol 34:7481\u20137491. https:\/\/doi.org\/10.1007\/s00330-024-10792-7","journal-title":"Eur Radiol"},{"key":"12395_CR72","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.eururo.2024.03.014","volume":"86","author":"C Engelman","year":"2024","unstructured":"Englman C, Maffei D, Allen C, et al (2024) PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer. Eur Urol. 86:240\u2013255","journal-title":"Eur Urol"},{"key":"12395_CR73","unstructured":"Philips (2020) Philips introduces industry-first vendor-neutral Radiology Operations Command Center at RSNA 2020. Available via https:\/\/www.usa.philips.com\/a-w\/about\/news\/archive\/standard\/news\/press\/2020\/20201124-philips-introduces-industry-first-vendor-neutral-radiology-operations-command-center-at-rsna-2020.html. Accessed 1 Sep 2025"},{"key":"12395_CR74","unstructured":"Cleveland Clinic (2023) Cleveland Clinic and Palantir Technologies partner to improve hospital performance through Virtual Command Center. Available via https:\/\/www.prnewswire.com\/news-releases\/cleveland-clinic-and-palantir-technologies-partner-to-improve-hospital-performance-through-virtual-command-center-301725481.html. Accessed 1 Sep 2025"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-026-12395-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-026-12395-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-026-12395-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T10:18:40Z","timestamp":1781864320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-026-12395-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":74,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["12395"],"URL":"https:\/\/doi.org\/10.1007\/s00330-026-12395-w","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Francesco Giganti.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare relationships with the following companies: A.B.D. has received speaker fees from Bayer. R.G. has served as a consultant for Bard, Bayer Pharma AG, Bracco Diagnostics, Philips, Quibim, and Roclub and has participated in the Speakers Bureau for Bayer Pharma AG. F.G. reports consulting fees from DeepHealth, SpectraCure and Procept outside of the submitted work. He has received speaker fees from Bayer and Siemens. R.G. is a deputy editor of\n                      European Radiology\n                      , S.U. and F.G. are members of the scientific editorial board for\n                      European Radiology\n                      , and G.V. is a member of the advisory editorial board for\n                      European Radiology\n                      ; as such, they did not participate in the selection or review processes for this article. The other authors declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}